Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans

BMC Biochemistry

Volumn 13, Issue 1, 2012, Pages

  Hanan, Sharif ^a   Jagarlamudi, Kiran Kumar ^a   Liya, Wang ^a   Ellen, He ^b   Staffan, Eriksson ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b Sino Swed Molecular Bio Medicine Research Institute   (China)

Author keywords

AZT; Canine; Human; Recombinant Thymidine Kinase 1; Serum Thymidine Kinase 1

Indexed keywords

BIOLOGICAL MARKER; CELL ENZYME; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT ENZYME; REDUCING AGENT; THYMIDINE DERIVATIVE; THYMIDINE KINASE 1; ZIDOVUDINE; RECOMBINANT PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CANINE LYMPHOMA; DNA SYNTHESIS; DOG; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME STABILITY; ENZYME STRUCTURE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOMA; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PHOSPHORYLATION; PROTEIN EXPRESSION; SPECIES DIFFERENCE; STRUCTURE ANALYSIS; WESTERN BLOTTING; AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; ENZYME SPECIFICITY; GEL CHROMATOGRAPHY; GENETICS; KINETICS; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN QUATERNARY STRUCTURE; SEQUENCE HOMOLOGY;

CANIS FAMILIARIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; THYMIDINE KINASE;

EID: 84864589670     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-13-12     Document Type: Article

References (25)

1. Structure and function of cellular deoxyribonucleoside kinases. Eriksson S, Munch-Petersen B, Johansson K, Eklund H, Cell Mol Life Sci 2002 59 1327 1346 10.1007/s00018-002-8511-x 12363036
2. Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. He Q, Skog S, Tribukait B, Cell Prolif 1991 24 3 14 10.1111/j.1365-2184.1991.tb01506.x 2009315
3. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan (TM) assays. Gasparri F, Wang NN, Skog S, Galvani A, Eriksson S, Eur J Cell Biol 2009 88 779 785 10.1016/j.ejcb.2009.06.005 19726104
4. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-Cdh1-mediated pathway. Ke PY, Chang ZF, Molecular an (Pubitemid 38057905)
5. Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes. Munch-Petersen B, Mol Cell Biochem 1984 64 173 185 6504022 (Pubitemid 15210257)
6. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. Munch-Petersen B, Tyrsted G, Cloos L, J Biol Chem 1993 268 15621 15625 8340387 (Pubitemid 23222058)
7. Structures of thymidine kinase 1 of human and mycoplasmic origin. Welin M, Kosinska U, Mikkelsen NE, Carnrot C, Zhu C, Wang L, Eriksson S, Munch-Petersen B, Eklund H, Proc Natl Acad Sci U S A 2004 101 17970 17975 10.1073/pnas.0406332102 15611477 (Pubitemid 40054059)
8. Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes. Segura-Pena D, Lichter J, Trani M, Konrad M, Lavie A, Lutz S, Structure 2007 15 1555 1566 10.1016/j.str.2007.09.025 18073106 (Pubitemid 350213413)
9. Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure. Segura-Pena D, Lutz S, Monnerjahn C, Konrad M, Lavie A, J Mol Biol 2007 369 129 141 10.1016/j.jmb.2007.02.104 17407781 (Pubitemid 46635429)
10. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B, Blood 1999 93 1732 1737 10029603 (Pubitemid 29102502)
11. Plasma thymidine kinase activity in dogs with lymphoma and leukemia. Nakamura N, Momoi Y, Watari T, Yoshino T, Tsujimoto H, Hasegawa A, J Vet Med Sci 1997 59 957 960 10.1292/jvms.59.957 9362053 (Pubitemid 127524338)
12. Serum thymidine kinase activity as a useful marker for bovine leukosis. Sakamoto L, Ohbayashi T, Matsumoto K, Kobayashi Y, Inokuma H, J Vet Diagn Invest 2009 21 871 874 10.1177/104063870902100619 19901293
13. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Gronowitz JS, Hagberg H, Kallander CF, Simonsson B, Br J Cancer 1983 47 487 495 10.1038/bjc.1983.78 6849793 (Pubitemid 13089615)
14. Serum thymidine kinase activity in dogs with amlignant lymphoma: a potent marker for prognosis and monitoring the disease. Von Euler HP, Olsson U, Lagerstedt A-S, Eriksson S, Vet Intren Med 2004 18 696 702 (Pubitemid 39406874)
15. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity-evaluation of a new, fully automated non-radiometric assay. Von Euler HP, Rivera P, Aronsson AC, Bengtsson C, Hansson LO, Eriksson S, International journal of oncology 2009 34 505 510 19148486
16. Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Zhang J, Jia Q, Zou S, Zhang P, Zhang X, Skog S, Luo P, Zhang W, He Q, Oncology reports 2006 15 455 461 16391869
17. Prognostic importance of thymidine kinase in colorectal and breast cancer. Svobodova S, Topolcan O, Holubec L, Treska V, Sutnar A, Rupert K, Kormunda S, Rousarova M, Finek J, Anticancer research 2007 27 1907 1909 17649793 (Pubitemid 46954696)
18. The half-life of thymidine kinase 1 in serum measured by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer. Zou L, Zhang PG, Zou S, Li Y, He Q, The International journal of biological markers 2002 17 135 140 12113581 (Pubitemid 34873800)
19. Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA. Karlstrom AR, Neumuller M, Gronowitz JS, Kallander CF, Mol Cell Biochem 1990 92 23 35 2155379 (Pubitemid 20044372)
20. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. Wang L, Munch-Petersen B, Sjoberg AH, Hellman U, Bergman T, Jornvall H, Eriksson S, FEBS Letters 1999 443 170 174 10.1016/S0014-5793(98)01711-6 9989599 (Pubitemid 29078626)
21. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma. Sharif H, Von Euler H, Westberg S, He E, Wang L, Eriksson S, The Veterinary Journal 2012 in press, available on line April 17
22. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease. Von Euler H, Einarsson R, Olsson U, Lagerstedt AS, Eriksson S, J Vet Intern Med 2004 18 696 702 15515587 (Pubitemid 39406874)
23. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs. Von Euler HP, Ohrvik AB, Eriksson SK, Res Vet Sci 2006 80 17 24 10.1016/j.rvsc.2005.05.001 16140350 (Pubitemid 41600833)
24. High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics. Birringer MS, Perozzo R, Kut E, Stillhart C, Surber W, Scapozza L, Folkers G, Protein Expr Purif 2006 47 506 515 10.1016/j.pep.2006.01.001 16473525 (Pubitemid 43729024)
25. Reversible tetramerization of human TK1 to the high catalytic efficient form is induced by pyrophosphate, in addition to tripolyphosphates, or high enzyme concentration. Munch-Petersen B, FEBS J 2009 276 571 580 10.1111/j.1742-4658.2008.06804.x 19087190